NCT07106879 - Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health. | Biotech Hunter

Enrollment

7,000

Participants

Timeline

Start Date

July 30, 2025

Primary Completion Date

July 1, 2030

Study Completion Date

December 1, 2030

Conditions

Cardiovascular DiseasesMetabolic SyndromeObesityPrediabetesMental Health DisordersEndocrine DysfunctionType 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease (CKD)

Interventions

OTHER

Blood Work

Collection of blood samples for metabolic and other necessary biomarker analysis, including Hemoglobin A1c (HbA1c), Lipid Panel, Liver and Kidney function tests and other protocol-defined assays.

Trial Locations (1)

11221

RECRUITING

Clindove Research LLC, Brooklyn